En
Búsqueda avanzada
Bibliografía

Guía de Práctica Clínica sobre las intervenciones terapéuticas en el Trastorno por Déficit de Atención con Hiperactividad
Completa HTML



 

  1. Grupo de trabajo para la actualización del Manual de Elaboración de GPC. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Actualización del Manual Metodológico: Ministerio de Sanidad, Servicios Sociales e Igualdad; Instituto Aragonés de Ciencias de la Salud (IACS); 2016. Available from: http://www.guiasalud.es.
  2. American Psychiatric Association. Manual diagnostico estadístico de los trastornos mentales V (DSM-5). Barcelona: Masson; 2014.
  3. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch J, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007;104(49).
  4. Sripada C, Kessler D, Angstadt M. Lag in maturation of the brain’s intrinsic functional architecture in attention-deficit/hyperactivity disorder. Proc Natl Acad Sci U S A 2014;111(39).
  5. Fernández-Perrone A, Marín Fernández-Mayoralas D, Fernández-Jaén A. Trastorno por déficit de atención/hiperactividad: del tipo inatento al tipo restrictivo. Rev Neurol 2013;56 (Supl 1).
  6. Willcutt E, Doyle A, Nigg J, Faraone S, Pennington B. Validity of the executive function theory of attention-defi cit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57(11).
  7. Barkley RA. Attention Deficit Hyperactivity Disorder. Nueva York: The Guilford Press; 2006.
  8. Goleman D. Inteligencia emocional: Kairós; 1995.
  9. Faraone S, Perlis R, Doyle A, Smoller J, Goralnick J, Holmgren M. Molecular genetics of attention-defi cit/hyperactivity disorder. Biol Psychiatry. 2005;57(11).
  10. Ministerio de Educación Cultura y Deporte. Respuesta educativa para alumnado con TDAH. ¿Qué es el TDAH?: Formación en Red: INTEF; 2012.
  11. National Institute for Health and Clinical Excellence (NICE). Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. Great Britain: The British Psychological Society and The Royal College of Psychiatrist; 2009.
  12. Scottish Intercollegiate Guidelines Network (SIGN). Management of attention déficit and hyperkinetic disorders in children and young people. A national clinical guideline2009.
  13. World Health Organization. CIE 10: Trastornos mentales y del comportamiento: descripciones clínicas y pautas para el diagnóstico. Ginebra: World Health Organization; 1992.
  14. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ. 2002;324(7342).
  15. Lasa-Zulueta A, Jorquera-Cuevas C. Evaluación de la situación asistencial y recomendaciones terapéuticas en el trastorno por déficit de atención e hiperactividad: Agencia de Evaluación de Tecnologías Sanitarias del País Vasco; 2009.
  16. Ley Orgánica 2/2006, de 3 de mayo, de Educación, BOE-A-2006-7899 (2006).
  17. López de Argumedo M, Reviriego E, Andrío E, Rico R, Sobradillo N, Hurtado de Saracho I. Revisión externa y validación de instrumentos metodológicos para la Lectura Crítica y la síntesis de la evidencia científica. Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluación de Tecnologías Sanitarias del País Vasco (Osteba); 2006. Informes de Evaluación de Tecnologías Sanitarias: OSTEBA Nº 2006/02.
  18. Langberg JM, Epstein JN, Girio-Herrera E, Becker SP, Vaughn AJ, Altaye M. Materials organization, planning, and homework completion in middle-school students with ADHD: Impact on academic performance. School Mental Health. 2011;3(2):93-101.
  19. Langberg JM, Molina BS, Arnold LE, Epstein JN, Altaye M, Hinshaw SP, et al. Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2011;40(4):519-31.
  20. Barkley RA, Fischer M. Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests. Dev Neuropsychol. 2011;36(2):137-61.
  21. Zentall S, Harper G, Stormont-Spurgin M. Children with hyperactivity and their organizational abilities. Journal of Educational Research. 1993;87(2).
  22. Power TJ, Werba BE, Watkins MW, Angelucci JG, Eiraldi RB. Patterns of parentreported homework problems among ADHD-referred and non-referred children. School Psychology Quarterly. 2006;21:13.
  23. Langberg JM, Arnold LE, Flowers AM, Epstein JN, Altaye M, Hinshaw SP, et al. Parentreported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol. 2010;39(2):220-33.
  24. Booster G, Dupaul G, Eiraldi R, Power T. Functional impairments in children with ADHD: unique effects of age and comorbid status. Atten Disord. 2012;16(3).
  25. Spear LP. Rewards, aversions and affect in adolescence: emerging convergences across laboratory animal and human data. Dev Cogn Neurosci 2011;1.
  26. DuPaul GJ, Kern L, Volpe R, Caskie GIL, Sokol N, Arbolino L, et al. Comparison of parent education and functional assessment-based intervention across 24 months for young children with attention deficit hyperactivity disorder. School Psychology Review. 2013;42(1):56-75.
  27. Abikoff H, Nissley-Tsiopinis J, Gallagher R, Zambenedetti M, Seyffert M, Boorady R, et al. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD. J Am Acad Child Adolesc Psychiatry. 2009;48(2):166-75.
  28. Langberg JM, Becker SP. Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder? Clin Child Fam Psychol Rev. 2012;15(3): 215-33.
  29. Power TJ, Mautone JA, Soffer SL, Clarke AT, Marshall SA, Sharman J, et al. A familyschool intervention for children with ADHD: results of a randomized clinical trial. J Consult Clin Psychol. 2012;80(4):611-23.
  30. Evans SW, Langberg J, Raggi V, Allen J, Buvinger E. Development of a school-based treatment program for middle school youth with ADHD. Journal of Attention Disorders. 2005;9.
  31. Evans SW, Serpell ZN, Schultz B, Pastor D. Cumulative benefits of secondary school-based treatment of students with ADHD. School Psychology Review. 2007;36.
  32. Pfiffner LJ, Mikami AY, Huatig-Pollock C, Easterlin B, Zalecki C, McBurrnet K. A randomized, comparison led trial of integrated homeschool behavioral treatment for ADHD, predominately inattentive type. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1041.
  33. Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, et al. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43.
  34. Abikoff H, Gallagher R, Wells KC, Murray DW, Huang L, Lu F, et al. Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial. J Consult Clin Psychol. 2013;81(1):113-28.
  35. Langberg JM, Epstein JN, Becker SP, Girio-Herrera E, Vaughn AJ. Evaluation of the Homework, Organization, and Planning Skills (HOPS) intervention for middle school students with attention deficit hyperactivity disorder as implemented by school mental health providers. School Psychology Review. 2012;41(3):342-64.
  36. Pfiffner LJ, Hinshaw SP, Owens E, Zalecki C, Kaiser NM, Villodas M, et al. A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type. J Consult Clin Psychol. 2014;82(6):1115-27.
  37. Pfiffner LJ, Villodas M, Kaiser N, Rooney M, McBurnett K. Educational outcomes of a collaborative school-home behavioral intervention for ADHD. School Psychology Quarterly. 2013;28(1):25-36.
  38. Boyer BE, Geurts HM, Prins PJ, Van der Oord S. Two novel CBTs for adolescents with ADHD: the value of planning skills. Eur Child Adolesc Psychiatry. 2015;24(9):1075-90.
  39. Sibley MH, Altszuler AR, Ross JM, Sanchez F, Pelham WE, Gnagy EM. A Parent-Teen Collaborative Treatment Model for Academically Impaired High School Students With ADHD. Cognitive and Behavioral Practice. 2014;21(1):32-42.
  40. Sadler JM, Evans SW, Schultz BK, Zoromski AK. Potential mechanisms of action in the treatment of social impairment and disorganization in adolescents with ADHD. School Mental Health. 2011;3(3):156-68.
  41. Janeslatt G, Kottorp A, Granlund M. Evaluating intervention using time aids in children with disabilities. Scandinavian journal of occupational therapy. 2014;21:181-90.
  42. Evans SW, Schultz BK, White LC, Brady C, Sibley MH, Van Eck K. A school-based organization intervention for young adolescents with attention-deficit/hyperactivity disorder. School Mental Health. 2009;1(2):78-88.
  43. Anastopoulos AD, King KA. A Cognitive-Behavior Therapy and Mentoring Program for College Students With ADHD. Cognitive and Behavioral Practice. 2015;22(2):141-51.
  44. Langberg JM, Vaughn AJ, Williamson P, Epstein JN, Girio-Herrera E, Becker SP. Refinement of an organizational skills intervention for adolescents with ADHD for implementation by school mental health providers. School Mental Health. 2011;3(3):143-55.
  45. Langberg JM, Becker SP, Epstein JN, Vaughn AJ, Girio-Herrera E. Predictors of response and mechanisms of change in an organizational skills intervention for students with ADHD. Journal of Child and Family Studies. 2013;22(7):1000-12.
  46. Mattingly G, Surman CB, Mao AR, Eagan CA, Onofrey M, Lerner M. Improving Communication in ADHD Care: Results from In-office Linguistic Research. CNS Spectrums. 2011;16.
  47. American Academy of Pediatrics. ADHD: Clinical practice guideline for the diagnosis, evaluation and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5).
  48. Power TJ, DuPaul GJ, Shapiro ES, Kazak AE. Promoting children’s health: Integrating school, family, and community. New York: Guilford Press; 2003.
  49. Toomey SL, Finkelstein J, Kuhlthau K. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics. 2008;122.
  50. Haute Autorité de Santé (HAS). Conduite à tenir en médecine de premier recours devant un enfant ou un adolescent susceptible d’avoir un trouble déficit de l’attention avec ou sans hyperactivité. Recommandation de bonne pratique. Argumentaire Scientifique. 2014.
  51. Mautone JA, Marshall SA, Sharman J, Eiraldi RB, Jawad AF, Power TJ. Development of a family-school intervention for young children with attention deficit hyperactivity disorder. School Psychology Review. 2012;41(4):447-66.
  52. Sibley MH, Pelham J, Derefinko KJ, Kuriyan AB, Sanchez F, Graziano PA. A pilot trial of supporting teens’ academic needs daily (STAND): A parent-adolescent collaborative intervention for ADHD. Journal of Psychopathology and Behavioral Assessment. 2013;35(4): 436-49.
  53. Myers K, Stoep AV, Thompson K, Zhou C, Unutzer J. Collaborative care for the treatment of Hispanic children diagnosed with attention-deficit hyperactivity disorder. Gen Hosp Psychiatry. 2010;32(6):612-4.
  54. Pfiffner LJ, Kaiser NM, Burner C, Zalecki C, Rooney M, Setty P, et al. From clinic to school: Translating a collaborative school-home behavioral intervention for ADHD. School Mental Health. 2011;3(3):127-42.
  55. Kolko DJ, Campo J, Kilbourne AM, Hart J, Sakolsky D, Wisniewski S. Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial. Pediatrics. 2014;133(4):e981-e92.
  56. Power TJ, Mautone JA, Marshall SA, Jones HA, Cacia J, Tresco K, et al. Feasibility and potential effectiveness of integrated services for children with ADHD in urban primary care practices. Clinical Practice in Pediatric Psychology. 2014;2(4):412-26.
  57. Earls MF. ADHD: collaboration on diagnosis and management among the medical home, school, and family. Pediatr Ann. 2014;43(5):165-6.
  58. Lynch SE, Cho J, Ogle S, Sellman H, Dosreis S. A phenomenological case study of communication between clinicians about attention-deficit/hyperactivity disorder assessment. Clin Pediatr (Phila). 2014;53(1):11-7.
  59. Moldavsky M, Sayal K. Knowledge and attitudes about attention-deficit/hyperactivity disorder (ADHD) and its treatment: the views of children, adolescents, parents, teachers and healthcare professionals. Current Psychiatry Reports. 2013;15(8):377.
  60. Brook JS, Brook DW, Zhang C, Seltzer N, Finch SJ. Adolescent ADHD and adult physical and mental health, work performance, and financial stress. Pediatrics. 2013;131(1):5-13.
  61. Mao AR, Babcock T, Brams M. ADHD in adults: Current treatment trends with consideration of abuse potential of medications. Journal of Psychiatric Practice. 2011;17(4).
  62. Sarkis E. Addressing attention-deficit/hyperactivity disorder in the workplace. Postgrad Med. 2014;126(5):25-30.
  63. Halmoy A, Fasmer O, Gillberg C, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13(2).
  64. University of Michigan Health System U. Attention Deficit Disorder Guideline. 2013.
  65. Brod M, Pohlman B, Lasser R, Hodgkins P. Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health and Quality of Life Outcomes. 2012;10.
  66. Canu WH, Newman ML, Morrow TL, Pope DL. Social appraisal of adult ADHD: stigma and infl uences of the beholder’s Big Five personality traits. J Atten Disord. 2008;11(6).
  67. Knapp M, King D, Healey A, Thomas C. Economic outcomes in adulthood and their associations with antisocial conduct, attention deficit and anxiety problems in childhood. Journal of Mental Health Policy and Economics. 2011;14(3):137-47.
  68. Young S, Toone B, Tyson C. Comorbidity and psychosocial profile of adults with attention deficit hyperactivity disorder. Personality and Individual Differences. 2003;35.
  69. Biederman J, Petty C, Fried R, Fontanella J, Doyle A, Seidman LJ, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry. 2006;163.
  70. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-23.
  71. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcomes of hyperactive children: adaptive functioning in major life activities. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45.
  72. Bjerrum MB, Pedersen PU, Larsen P, Berring LL. Living with symptoms of attention deficithyperactivity disorder (adhd) in adulthood: A systematic review protocol of qualitative evidence. JBI Database of Systematic Reviews and Implementation Reports. 2013;11(3).
  73. Mao AR, Brams M, Babcock T, Madhoo M. A physician’s guide to helping patients with ADHD find success in the workplace. Postgrad Med. 2011;123(5):60-70.
  74. De Graaf R, Kessler RC, Fayyad J, Ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: Results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008;65.
  75. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012;10.
  76. Primich C, Iennaco J. Diagnosing adult attention-deficit hyperactivity disorder: the importance of establishing daily life contexts for symptoms and impairments. J Psychiatr Ment Health Nurs. 2012;19(4).
  77. Katz LJ. Providing opportunities in the workplace for individuals with ADD. Employ Relat Today. 2003;30(2).
  78. Nadeau KG. Career choices and workplace challenges for individuals with ADHD. J Clin Psychol. 2005;61(5).
  79. Abraham A, Windmann S, Siefen R, Daum I, Gunturkun O. Creative thinking in adolescents with attention deficit hyperactivity disorder (ADHD). Child Neuropsychol. 2006;12(2).
  80. Healey D, Rucklidge JJ. An investigation into the relationship among ADHD symptomatology, creativity, and neuropsychological functioning in children. Child Neuropsychol. 2006; 12(6).
  81. Henry E, Jones SH. Experiences of older adult women diagnosed with attention deficit hyperactivity
    disorder. J Women Aging. 2011;23(3):246-62.
  82. DuPaul GJ, Stoner G. ADHD in the schools: Assessment and intervention strategies. New York: Guilford Press; 2003.
  83. Abad-Mas L, Ruiz-Andrés R, Moreno-Madrid F, Herrero R, Suay E. Intervención psicopedagógica en el trastorno por déficit de atención/hiperactividad. Revista de neurología. 2013.
  84. Pfiffner LJ, Haack LM. Behavior management for school-aged children with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):731-46.
  85. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I An 8-year prospective follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry. 1990;29(4).
  86. Pfiffner LJ, Calzada E, McBurnett K. Interventions to enhance social competence. Child and Adolescent Psychiatric Clinics of North America. 2000;9(3).
  87. Fischer M, Barkley RA, Fletcher KE, Smallish L. The stability of dimensions of behavior in ADHD and normal children over an 8-year followup. J Abnorm Child Psychol. 1993;21(3): 315-37.
  88. Kuriyan AB, Pelham WEJr, Molina BS, Waschbusch DA, Gnagy EM, Sibley MH, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. Journal of Abnormal Child Psychology. 2013;41(1).
  89. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder. Attention deficit hyperactivity disorder. Evidence Update 45. July 2013. A summary of selected new evidence relevant to NICE clinical guideline 72 ‘Diagnosis and management of ADHD in children, young people and adults’ (2009)2013.
  90. Grupo de trabajo de la Guía de Práctica Clínica sobre el Trastorno por Déficit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Guía de Práctica Clínica sobre el Trastorno por Déficit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad; Agència d’Informació, Avaluació i Qualitat (AIAQS); 2010.
  91. Richardson M, Moore DA, Gwernan-Jones R, Thompson-Coon J, Ukoumunne O, Rogers M, et al. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research. Health Technol Assess. 2015;19(45):1-470.
  92. Chacko A, Bedard AC, Marks DJ, Feirsen N, Uderman JZ, Chimiklis A, et al. A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition. Journal of child psychology and psychiatry, and allied disciplines. 2014;55:247-55.
  93. DuPaul GJ, Eckert TL, Vilardo B. The effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis 1996-2010. School Psychology Review. 2012;41(4):387-412.
  94. Melby-Lervag M, Hulme C. Is working memory training effective? A meta-analytic review. Dev Psychol. 2013;49(2):270-91.
  95. Miller FG, Lee DL. Do functional behavioral assessments improve intervention effectiveness for students diagnosed with ADHD? A single-subject meta-analysis. Journal of Behavioral Education. 2013;22(3):253-82.
  96. Evans SW, Schultz BK, DeMars CE. High school-based treatment for adolescents with attention-deficit/hyperactivity disorder: Results from a pilot study examining outcomes and dosage. School Psychology Review. 2014;43(2):185-202.
  97. Lloyd A, Brett D, Wesnes K. Coherence training in children with attention-deficit hyperactivity disorder: cognitive functions and behavioral changes. Alternative therapies in health and medicine. 2010;16:34-42.
  98. Egeland J, Aarlien AK, Saunes BK. Few Effects of Far Transfer of Working Memory Training in ADHD: A Randomized Controlled Trial. PloS one. 2013;8.
  99. Gropper RJ, Gotlieb H, Kronitz R, Tannock R. Working memory training in college students with ADHD or LD. J Atten Disord. 2014;18(4):331-45.
  100. Tamm L, Epstein JN, Peugh JL, Nakonezny PA, Hughes CW. Preliminary data suggesting the efficacy of attention training for school-aged children with ADHD. Developmental cognitive neuroscience. 2013;4:16-28.
  101. Owens JS, Holdaway AS, Zoromski AK, Evans SW, Himawan LK, Girio-Herrera E, et al. Incremental benefits of a daily report card intervention over time for youth with disruptive behavior. Behav Ther. 2012;43(4):848-61.
  102. Watabe Y, Stewart JL, Owens JS, Andrews N, Griffeth JC. Effectiveness and sustainability of school-based interventions for youth with or at risk for ADHD. School Mental Health. 2013;5(2):83-95.
  103. Sibley MH, Smith BH, Evans SW, Pelham WE, Gnagy EM. Treatment response to an intensive summer treatment program for adolescents with ADHD. Journal of Attention Disorders. 2012;16(6):443-8.
  104. Derefinko KJ, Hayden A, Sibley MH, Duvall J, Milich R, Lorch EP. A story mapping intervention to improve narrative comprehension deficits in adolescents with ADHD. School Mental Health. 2014;6(4):251-63.
  105. Smith AL, Hoza B, Linnea K, McQuade JD, Tomb M, Vaughn AJ, et al. Pilot physical activity intervention reduces severity of ADHD symptoms in young children. Journal of Attention Disorders. 2013;17(1):70-82.
  106. Hariri AA, Faisal E. Effects of teaching art activities by using the playing method to develop skills in preschool children with attention deficit hyperactivity disorder. Journal on Developmental Disabilities. 2013;19(1):79-89.
  107. Guderjahn L, Gold A, Stadler G, Gawrilow C. Self-regulation strategies support children with ADHD to overcome symptom-related behavior in the classroom. ADHD Attention Deficit and Hyperactivity Disorders. 2013;5(4):397-407.
  108. Serrano-Troncoso E, Guidi M, Alda-Díez JA. ¿Es el tratamiento psicológico eficaz para el trastorno por déficit de atención con hiperactividad (TDAH)? Revisión sobre los tratamientos no famacológicos en niños y adolescentes con TDAH. Actas Españolas de Psiquiatría. 2013;41(1):44-51.
  109. Catala-Lopez F, Hutton B, Nunez-Beltran A, Mayhew AD, Page MJ, Ridao M, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2015;4:19.
  110. Storebo OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015(11):Cd009885.
  111. Childress AC, Spencer T, Lopez F, Gerstner O, Thulasiraman A, Muniz R, et al. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 2009;19(4):351-61.
  112. Castells X, Cunill R, Capella D. Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. Eur J Clin Pharmacol. 2013;69(3):347-56.
  113. Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs. 2011;25(2):157-69.
  114. Takahashi N, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. The World Journal of Biological Psychiatry. 2014;15(6):488-98.
  115. Retz W, Rösler M, Ose C, Scherag A, Alm B, Philipsen A, et al. Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. The World Journal of Biological Psychiatry. 2012;13(1):48-59.
  116. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24- week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience. 2009; 259(2):120-9.
  117. Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, et al. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials. Drug Des Devel Ther. 2015;9:1927-36.
  118. Banaschewski T, Soutullo C, Lecendreux M, Johnson M, Zuddas A, Hodgkins P, et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs. 2013;27(10):829-40.
  119. Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, et al. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. European Neuropsychopharmacology. 2013;23 (10):1208-18.
  120. Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD. Drug Des Devel Ther. 2014;8:1685-93.
  121. Adler LA, Dirks B, Deas P, Raychaudhuri A, Dauphin M, Saylor K, et al. Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: A randomized, double-blind, multicenter, placebo-controlled, parallel-group study. BMC psychiatry. 2013;13.
  122. Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, et al. Lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder who report clinically significant impairment in executive function: Results from a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry. 2013;74(7):694-702.
  123. Pringsheim T, Hirsch L, Gardner D, Gorman DA. The pharmacological management of oppositional behaviour, conduct problems, and aggression in Children and adolescents with attention- deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: A systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2 agonists, and atomoxetine. Canadian Journal of Psychiatry. 2015;60(2):42-51.
  124. Ruggiero S, Clavenna A, Reale L, Capuano A, Rossi F, Bonati M. Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24(10):1578-90.
  125. Young J, Rugino T, Dammerman R, Lyne A, Newcorn JH. Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners’ Parent Rating Scale-revised: Short Form. Journal of Child and Adolescent Psychopharmacology. 2014;24(8):435-41.
  126. Schwartz S, Correll CU. Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiatry. 2014;53(2):174-87.
  127. Escobar R, Montoya A, Polavieja P, Cardo E, Artigas J, Hervas A, et al. Evaluation of patients’ and parents’ quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(3): 253-63.
  128. Cunill R, Castells X, Tobias A, Capella D. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. Pharmacoepidemiol Drug Saf. 2013;22(9):961-9.
  129. Gorman DA, Gardner DM, Murphy AL, Feldman M, Belanger SA, Steele MM, et al. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry. 2015;60(2):62-76.
  130. Pringsheim T, Hirsch L, Gardner D, Gorman DA. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers. Canadian journal of psychiatry Revue canadienne de psychiatrie. 2015;60(2):52-61.
  131. Fridman M, Hodgkins PS, Kahle JS, Erder MH. Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis. Eur Psychiatry. 2015;30(4):521-7.
  132. Epstein T, Patsopoulos NA, Weiser M. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2014;9:CD005041.
  133. Epstein T, Patsopoulos NA, Weiser M. WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2016(5):Cd005041.
  134. Boesen K, Saiz LC, Erviti J, Storebo OJ, Gluud C, Gotzsche PC, et al. The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder. Evidence-based medicine. 2017;22(4):143-7.
  135. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
  136. Caisley H, Muller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry. 2012;27(5):343-9.
  137. Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184-91.
  138. Van de Loo-Neus GH, Rommelse N, Buitelaar JK. To stop or not to stop? How long should
    medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol. 2011;21(8):584-99.
  139. Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, et al. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry. 2011;20(1):17-37.
  140. Ibrahim K, Donyai P. Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades. J Atten Disord. 2015;19(7):551-68.
  141. Coghill DR, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson CS, et al. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: Randomized-withdrawal study design. Journal of the American Academy of Child & Adolescent Psychiatry. 2014;53(6):647-57.
  142. Braun S, Russo L, Zeidler J, Linder R, Hodgkins P. Descriptive comparison of drug treatmentpersistent,
    -non persistent, and non drug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany. Clin Ther. 2013;35(5):673-85.
  143. Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, et al. Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Preference and Adherence. 2013;7:987-95.
  144. Marcus SC, Durkin M. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(5): 480-9.
  145. Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009;48(5):501-10.
  146. Zetterqvist J, Asherson P, Halldner L, Langstrom N, Larsson H. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatr Scand. 2013;128(1):70-7.
  147. Christensen L, Sasane R, Hodgkins P, Harley C, Tetali S. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin. 2010;26(4):977-89.
  148. Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)–a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009;13(50):iii-xi, 1.
  149. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194(3):273-7.
  150. O’Callaghan P. Adherence to stimulants in adult ADHD. Atten Defic Hyperact Disord. 2014;6(2):111-20.
  151. Chen CY, Yeh HH, Chen KH, Chang IS, Wu EC, Lin KM. Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/ hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 2011;21(3):265-73.
  152. Chacko A, Newcorn JH, Feirsen N, Uderman JZ. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des. 2010;16(22):2416-23.
  153. Atzori P, Usala T, Carucci S, Danjou F, Zuddas A. Predictive factors for persistent use and compliance of immediate-release methylphenidate: A 36-month naturalistic study. Journal of Child and Adolescent Psychopharmacology. 2009;19(6):673-81.
  154. Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V. Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012;22(3):226-37.
  155. dosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA. The meaning of attention-deficit/hyperactivity disorder medication and parentsGÇÖ initiation and continuity of treatment for their child. Journal of Child and Adolescent Psychopharmacology. 2009;19(4):377-83.
  156. Cormier E. How parents make decisions to use medication to treat their child’s ADHD: a grounded theory study. J Am Psychiatr Nurses Assoc. 2012;18(6):345-56.
  157. Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, et al. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder. Pediatrics. 2009;124(2):580-9.
  158. Herbert SD, Harvey EA, Roberts JL, Wichowski K, Lugo-Candelas CI. A randomized controlled trial of a parent training and emotion socialization program for families of hyperactive preschool-aged children 7. Behavior Therapy. 2013;44(2):302-16.
  159. Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, et al. In their own words: adolescent views on ADHD and their evolving role managing medication. Acad Pediatr. 2012;12(1):53-61.
  160. Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry. 2013;54(3): 227-46.
  161. Charach A, Dashti B, Carson P, Booker L, Lim CG, Lillie E, et al. AHRQ Comparative Effectiveness Reviews. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
  162. Fredriksen M, Halmoy A, Faraone SV, Haavik J. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol. 2013;23(6):508-27.
  163. Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey. J Clin Psychiatry. 2013;74(1):e87-e93.
  164. Molina BS, Hinshaw SP, Eugene AL, Swanson JM, Pelham WE, Hechtman L, et al. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013;52(3): 250-63.
  165. Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, et al. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013;203(2):112-9.
  166. Harty SC, Ivanov I, Newcorn JH, Halperin JM. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol. 2011;21(4): 331-9.
  167. Peyre H, Hoertel N, Cortese S, Acquaviva E, Limosin F, Delorme R. Long-term effects of ADHD medication on adult height: results from the NESARC. J Clin Psychiatry. 2013;74(11): 1123-4.
  168. Poulton AS, Melzer E, Tait PR, Garnett SP, Cowell CT, Baur LA, et al. Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder. Med J Aust. 2013;198(1):29-32.
  169. Dura-Trave T, Yoldi-Petri ME, Gallinas-Victoriano F, Zardoya-Santos P. Effects of osmoticrelease methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment. J Child Neurol. 2012;27(5):604-9.
  170. Biederman J, Spencer TJ, Monuteaux MC, Faraone SV. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr. 2010;157(4):635-40, 40.
  171. Zhang H, Du M, Zhuang S. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD. Neuropediatrics. 2010;41(2):55-9.
  172. Arnold LE, Hodgkins P, Caci H, Kahle J, Young S. Effect of treatment modality on longterm outcomes in attention-deficit/hyperactivity disorder: A systematic review. PLoS ONE. 2015;10(2).
  173. van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study. Clin Psychol Psychother. 2012;19(3):270-8.
  174. Moungnoi P, Maipang P. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health. J Med Assoc Thai. 2011;94 Suppl 3:S158-S63.
  175. Valdizán-Uson JR, Cánovas-Martinez A, De Lucas-Taracena MT, Díaz-Atienza F, Eddy-Ives LS, Fernández-Jaen A, et al. Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: The spanish multicenter dihana study. Neuropsychiatric Disease and Treatment. 2013;9:211-8.
  176. Valverde M, Inchauspe J. Alcance y limitaciones del tratamiento farmacológico del Trastorno por Déficit de Atención e Hiperactividad en niños y adolescentes y Guías de Práctica Clínica. Una revisión bibliográfica. Rev Asoc Esp Neuropsiq. 2014;34(121).
  177. Rodríguez A. La investigación de resultados y el futuro de la psicoterapia: alternativas a los tratamientos empíricamente validados. Papeles del psicólogo [Internet]. 2004; (87). Available from:http://www.uma.es/psicologia/docs/eudemon/divulgacion/investigacion_de_resultados_ y_futuro_de_la_psicoterapia.pdf.
  178. Bados A. La intervención psicológica: características y modelos. Barcelona: Universidad de Barcelona, Facultad de Psicología; 2008. Available from: http://diposit.ub.edu/dspace/bitstream/2445/4963/1/IPCS%20caracter%C3%ADsticas%20y%20modelos.pdf.
  179. Ramírez M. Tratamiento cognitivo-conductual de conductas disruptivas en un niño con TDAH y trastorno negativista desafiante. Revista de Psicología Clínica con Niños y Adolescentes 2015;2(1):45-54.
  180. Orjales I. El tratamiento cognitivo en niños con trastorno por déficit de atención con hiperactividad(TDAH): revisión y nuevas aportaciones Anuario de Psicología Clínica y de la Salud / Annuary of Clinical and Health Psychology [Internet]. 2007; (3):[19-30 pp.]. Available from: http://institucional.us.es/apcs/doc/APCS_3_esp_19-30.pdf.
  181. Vallejo MA. El Mindfulness y la «tercera generación de terapias psicológicas». Infocop [Internet]. 2007; (33). Available from: http://www.infocop.es/view_article.asp?id=1465.
  182. Beyebach M. «Más papas y menos pastillas»: la terapia familiar colaborativa y basada en fortalezas en la intervención con niños y sus familias. Available from: http://www.gaztedi.eus/files/Mas-papas-y-menos-pastillas.pdf.
  183. Moriyama TS, Polanczyk GV, Terzi FS, Faria KM, Rohde LA. Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available metaanalyses. CNS Spectr. 2013;18(6):296-306.
  184. Virta M, Salakari A, Antila M, Chydenius E, Partinen M, Kaski M, et al. Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study. Neuropsychiatr Dis Treat. 2010;6:443-53.
  185. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: A randomized controlled trial. JAMA: Journal of the American Medical Association. 2010;304(8):875-80.
  186. Vidal-Estrada R, Bosch-Munso R, Nogueira-Morais M, Casas-Brugue M, Ramos-Quiroga JA. Psychological treatment of attention deficit hyperactivity disorder in adults: a systematic review. Actas Esp Psiquiatr. 2012;40(3):147-54.
  187. Chandler ML. Psychotherapy for adult attention deficit/hyperactivity disorder: A comparison with cognitive behaviour therapy. Journal of Psychiatric and Mental Health Nursing. 2013;20(9):814-20.
  188. Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, Smith BH. Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature. Clin Psychol Rev. 2014;34(3):218-32.
  189. Vidal R, Castells J, Richarte V, Palomar G, Garcia M, Nicolau R, et al. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(4):275-82.
  190. Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with Attention-Deficit/Hyperactivity Disorder and substance use disorders. Journal of the American Academy of Child & Adolescent Psychiatry. 2011;50(9): 903-14.
  191. Vitiello B, Elliott GR, Swanson JM, Arnold LE, Hechtman L, Abikoff H, et al. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry. 2012;169(2):167-77.
  192. Prevatt F, Yelland S. An Empirical Evaluation of ADHD Coaching in College Students. J Atten Disord. 2015;19(8):666-77.
  193. Vidal R, Bosch R, Nogueira M, Gomez-Barros N, Valero S, Palomar G, et al. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study. J Nerv Ment Dis. 2013;201(10):894-900.
  194. Hirvikoski T, Waaler E, Alfredsson J, Pihlgren C, Holmström A, Johnson A, et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behav Res Ther. 2011;49(3).
  195. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010;167(8):958-68.
  196. Johnston C, Mash EJ. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clinical child and family psychology review. 2001;4(3):183-207.
  197. Salmeron PA. Childhood and adolescent attention-deficit hyperactivity disorder: diagnosis, clinical practice guidelines, and social implications. J Am Acad Nurse Pract 2009;21.
  198. Hurt EA, Hoza B, Pelham WE, Jr. Parenting, family loneliness, and peer functioning in boys with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol. 2007;35(4):543-55.
  199. Keown LJ. Predictors of boys’ ADHD symptoms from early to middle childhood: the role of father-child and mother-child interactions. J Abnorm Child Psychol. 2012;40(4):569-81.
  200. Heath Corey L, Curtis D, Fan W, McPherson R. The association between parenting stress, parenting self-efficacy, and the clinical significance of child ADHD symptom change following behavior therapy. Child psychiatry and human development. 2015;46(1):118-29.
  201. Zwi M, Jones H, Thorgaard C, York A, Dennis JA. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011.
  202. Mulqueen JM, Bartley CA, Bloch MH. Meta-analysis: parental interventions for preschool ADHD. J Atten Disord. 2015;19(2):118-24.
  203. Coates J, Taylor JA, Sayal K. Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis. J Atten Disord. 2015;19(10):831-43.
  204. Lee PC, Niew WI, Yang HJ, Chen VC, Lin KC. A meta-analysis of behavioral parent training for children with attention deficit hyperactivity disorder. Research in developmental disabilities. 2012;33(6):2040-9.
  205. Hauth-Charlier S, Clément C. Abord développemental du TDAH: Efficacité d’un programme d’entraînement aux habiletés parentales. Canadian Journal of Behavioural Science / Revue canadienne des sciences du comportement. 2014;46(2):107-16.
  206. Xie Y, Dixon JF, Yee OM, Zhang J, Chen YA, Deangelo S, et al. A study on the effectiveness of videoconferencing on teaching parent training skills to parents of children with ADHD. Telemedicine journal and e health. 2013;19:192-9.
  207. Azevedo AF, Seabra-Santos MJo, Gaspar MF, Homem TC. The Incredible Years Basic Parent Training for Portuguese preschoolers with AD/HD behaviors: Does it make a difference? Child & Youth Care Forum. 2013;42(5):403-24.
  208. Daley D, O’Brien M. A small-scale randomized controlled trial of the self-help version of the New Forest Parent Training Programme for children with ADHD symptoms. European child & adolescent psychiatry. 2013;22:543-52.
  209. Abikoff HB, Thompson M, Laver-Bradbury C, Long N, Forehand RL, Miller BL, et al. Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs. J Child Psychol Psychiatry. 2015;56(6):618-31.
  210. Fabiano GA, Chacko A, Pelham WE, Jr., Robb J, Walker KS, Wymbs F, et al. A comparison of behavioral parent training programs for fathers of children with attention-deficit/hyperactivity disorder. Behav Ther. 2009;40(2):190-204.
  211. Fabiano GA, Pelham WE, Cunningham CE, Yu J, Gangloff B, Buck M, et al. A waitlistcontrolled trial of behavioral parent training for fathers of children with ADHD. J Clin Child Adolesc Psychol. 2012;41(3):337-45.
  212. Thorell LB. The community parent education program (COPE): Treatment effects in a clinical and a community-based sample. Clinical Child Psychology and Psychiatry. 2009;14(3): 373-87.
  213. Stattin H, Enebrink P, Özdemir M, Giannotta F. A National Evaluation of Parenting Programs in Sweden: The Short-Term Effects Using an RCT Effectiveness Design. Journal of Consulting and Clinical Psychology. 2015.
  214. Au A, Lau KM, Wong AHC, Lam C, Leung C, Lau J, et al. The efficacy of a group Triple P (positive parenting program) for Chinese parents with a child diagnosed with ADHD in Hong Kong: A pilot randomised controlled study. Australian Psychologist. 2014;49(3): 151-62.
  215. Huang HL, Lu CH, Tsai HW, Chao CC, Ho TY, Chuang SF, et al. Effectiveness of Behavioral Parent Therapy in Preschool Children With Attention-Deficit Hyperactivity Disorder 31. Kaohsiung Journal of Medical Sciences. 2009;25(7):357-65.
  216. Canu WH, Bearman SK. Community-clinic-based parent intervention addressing noncompliance in children with attention-deficit/hyperactivity disorder. Cognitive and Behavioral Practice. 2011;18(4):491-501.
  217. Malik TA, Tariq N. Parent training in reduction of attention-deficit/hyperactivity disorder and oppositional defiant disorder symptoms in children. Pakistan Journal of Psychological Research. 2014;29(1):151-69.
  218. Trillingsgaard T, Trillingsgaard A, Webster-Stratton C. Assessing the effectiveness of the ‘Incredible Years((R)) parent training’ to parents of young children with ADHD symptoms – a preliminary report. Scand J Psychol. 2014;55(6):538-45.
  219. Shata ZN, bu-Nazel MW, Fahmy SI, El-Dawaiaty AA. Efficacy of a psychosocial intervention for parents of children with attention deficit hyperactivity disorder, Alexandria, Egypt. J Egypt Public Health Assoc. 2014;89(1):9-15.
  220. Perrin EC, Sheldrick RC, McMenamy JM, Henson BS, Carter AS. Improving parenting skills for families of young children in pediatric settings: A randomized clinical trial. JAMA Pediatrics. 2014;168(1):16-24.
  221. Rajwan E, Chacko A, Wymbs BT, Wymbs FA. Evaluating clinically significant change in mother and child functioning: comparison of traditional and enhanced behavioral parent training. J Abnorm Child Psychol. 2014;42(8):1407-12.
  222. Fernandes AA, Seabra-Santos MJ, Gaspar MF, Homem T. A parent-based intervention programme involving preschoolers with AD/HD behaviours: are children’s and mothers’ effects sustained over time? Eur Child Adolesc Psychiatry. 2014;23(6):437-50.
  223. Kaminski JW, Valle LA, Filene JH, Boyle CL. A meta-analysis review of components associated with parent training program effectiveness. J Abnorm Child Psychol 2008;36.
  224. Charach A, Carson P, Fox S, Ali MU, Beckett J, Lim CG. Interventions for preschool children at high risk for ADHD: A comparative effectiveness review. Pediatrics. 2013;131(5): e1584-e604.
  225. Webster-Stratton C, Reid MJ, Beauchaine TP. One-year follow-up of combined parent and child intervention for young children with ADHD. J Clin Child Adolesc Psychol. 2013;42 (2): 251-61.
  226. Hautmann C, Hoijtink H, Eichelberger I, Hanisch C, Pluck J, Walter D, et al. One-year follow- up of a parent management training for children with externalizing behaviour problems in the real world. Behav Cogn Psychother. 2009;37(4):379-96.
  227. Koerting J, Smith E, Knowles MM, Latter S, Elsey H, McCann DC, et al. Barriers to, and facilitators of, parenting programmes for childhood behaviour problems: a qualitative synthesis of studies of parents’ and professionals’ perceptions. Eur Child Adolesc Psychiatry. 2013; 22(11):653-70.
  228. Smith E, Koerting J, Latter S, Knowles MM, McCann DC, Thompson M, et al. Overcoming barriers to effective early parenting interventions for attention-deficit hyperactivity disorder (ADHD): parent and practitioner views. Child Care Health Dev. 2015;41(1):93-102.
  229. Beaulieu MC, Normandeau S, Robaey P. Les cognitions sociales des parents d’enfants TDA/H comme prédicteur des pratiques parentales après une intervention. Revue canadienne des sciences du comportement. 2014;46(2):147-61.
  230. Johnston C, Mah JW, Regambal M. Parenting cognitions and treatment beliefs as predictors of experience using behavioral parenting strategies in families of children with attention-deficit/hyperactivity disorder. Behav Ther. 2010;41(4):491-504.
  231. Lerner MD, Mikami AY, McLeod BD. The alliance in a friendship coaching intervention for parents of children with ADHD. Behavior Therapy. 2011;42(3):449-61.
  232. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World psychiatry : official journal of the World Psychiatric Association (WPA). 2003;2(2):104-13.
  233. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53 (1):34-46.e2.
  234. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological medicine. 2006;36(2):159-65.
  235. Faraone SV, Spencer TJ, Montano CB, Biederman J. Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Archives of internal medicine. 2004;164(11):1221-6.
  236. Torgersen T, Gjervan B, Lensing MB, Rasmussen K. Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat. 2016;12:79-87.
  237. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, et al. Childhood predictors of adult ADHD: Results from the WHO World Mental Health (WMH) Survey Initiative. Biol Psychiatry 2009;65(1):46-54.
  238. Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. Am J Psychiatry. 2015;172(10):967-77.
  239. Young S, Fitzgerald M y Postma JM. TDAH: Hacer visible lo invisible. Libro blanco europeo sobre el TDAH. Bruselas: European Brain Council – GAMIANEurope; 2013.
  240. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152(11):1652-8.
  241. Wilens TE, Biederman J, Abrantes AM, Spencer TJ. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(7).
  242. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attentiondeficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1).
  243. Agarwal R, Goldenberg M, Perry R, Ishak WW. The quality of life of adults with attention deficit hyperactivity disorder: A systematic review. Innovations in Clinical Neuroscience. 2012;9(5-6):10-21.
  244.  Hansson Halleröd SL, Anckarsäter H, Rastam M, Hansson Scherman M. Experienced consequences of being diagnosed with ADHD as an adult – a qualitative study. BMC psychiatry. 2015;15:31.
Anexos
Introducción